⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28176124 | 0.98 | — | — | |
| SCHEMBL17219181 | 0.82 | — | — | |
| SCHEMBL17218164 | 0.79 | CES1 (0.32) | — | |
| SCHEMBL21799409 | 0.76 | — | — | |
| SCHEMBL21799408 | 0.76 | — | — | |
| SCHEMBL19254983 | 0.75 | — | — | |
| SCHEMBL17215808 | 0.71 | — | — | |
| SCHEMBL13431422 | 0.71 | — | — | |
| SCHEMBL5207983 | 0.71 | — | — | |
| SCHEMBL14315391 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2940012-B1 | TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF | SUMITOMO CHEMICAL CO (JP) | 2019-01-30 | — | — | EP | disclosed |
| CN-104428282-B | Oxime-substituted amide compound and pest control agent | 日产化学工业株式会社 | 2017-10-20 | — | — | CN | disclosed |
| CN-107266333-A | Oxime substituted amide compound and noxious organism control agent | 日产化学工业株式会社 | 2017-10-20 | — | — | CN | disclosed |
| US-9560850-B2 | Tetrazolinone compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-07 | — | — | US | disclosed |
| US-20150336908-A1 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-26 | — | — | US | disclosed |
| EP-2940012-A1 | TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF | Sumitomo Chemical Company Limited (JP) | 2015-11-04 | — | — | EP | disclosed |